Andrea M. Douglas

423 citations
8 papers · 366 indexed · h-index 8
Topics
Cytokine Signaling Pathways and Interactions (4 papers)interferon and immune responses (1 paper)Cell death mechanisms and regulation (1 paper)

In The Last Decade

Andrea M. Douglas

8 papers receiving 352 citations

Peers

Andrea M. Douglas
Comparison fields: 5 of 60
  • Oncology 189
  • Molecular Biology 155
  • Immunology 87
  • Pathology and Forensic Medicine 68
  • Cancer Research 49
Replace Masanobu Oishi with:
Masanobu Oishi Japan
Johji Inazawa Japan
Birgit Langhans Germany
Martina Gogarty Ireland
Keara L. Redmond United Kingdom
Laia Trigueros‐Motos Spain
Angelika Gillitzer Germany
Tomohiko Iwakura Japan
Raymond E. Menard United States
Andrea M. Douglas relative to Masanobu Oishi Japan Masanobu Oishi's profile →
Citations per field
00.5×3.1×
Masanobu Oishi · 1×
Citations per year

Countries citing papers authored by Andrea M. Douglas

Since Specialization
Citations

This map shows the geographic impact of Andrea M. Douglas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea M. Douglas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea M. Douglas more than expected).

Fields of papers citing papers by Andrea M. Douglas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea M. Douglas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea M. Douglas. The network helps show where Andrea M. Douglas may publish in the future.

Co-authorship network of co-authors of Andrea M. Douglas

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea M. Douglas. A scholar is included among the top collaborators of Andrea M. Douglas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea M. Douglas. Andrea M. Douglas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 50
2 42
3 67
4 86
5 21
6 13
7 17
8 70

About Andrea M. Douglas

Andrea M. Douglas is a scholar working on Pharmacology, Oncology and Immunology and Allergy, having authored 8 papers that have together received 366 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (4 papers), interferon and immune responses (1 paper) and Cell death mechanisms and regulation (1 paper). The work is most often cited by research in Oncology (189 citations), Pharmacology (37 citations) and Immunology (87 citations). Andrea M. Douglas has collaborated with scholars based in Australia, United Kingdom and Canada. Frequent co-authors include Geraldine A. Goss, C. Glenn Begley, N. V. Ricchiuti, Robert L. Sutherland, Douglas J. Hilton, Michael C. Berndt, Nicos A. Nicola, C. Glenn Begley, David Clouston and Robert L. Sutherland. Their work appears in journals such as Circulation Research, Oncogene and Analytical Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026